James Thomson
Group Chief Commercial Officer
James joined UHL Group in July 2025 in a shared role covering LUHFT, Liverpool Women’s NHS Foundation Trust, Clatterbridge Cancer Centre and Liverpool Heart and Chest Hospital.
Previously, James was Chief Finance Officer at Liverpool Heart and Chest Hospital, a role he has held since February 2024, and Director of Finance at Clatterbridge Cancer Centre, a role he has held since 2019. He has held several senior finance positions in the healthcare sector, including Director of Finance at Liverpool Heart and Chest Hospital and Deputy Director of Finance at The Christie in Manchester.
James has a strong focus on financial delivery, commercial development and is committed to supporting excellent patient care through sustainable financial planning and decision making. As part of his role at Clatterbridge, James operates as the executive director representative for the centre’s wholly owned subsidiary companies, Clatterbridge Pharmacy Ltd (trading as 'PharmaC') and PropCare (contract management), both of which return profit to the NHS.